Retour sur lavenir.net
   DEME GROUP 169.000 € (+0,12 %)     CELYAD ONCOLOGY 0.250 € (-9,42 %)     WDP 22.400 € (+1,36 %)     AB INBEV 72.520 € (+1,45 %)     VGP 82.700 € (+1,97 %)     FAGRON 23.700 € (-0,63 %)     ENERGYVISION 14.840 € (+0,27 %)     XIOR 27.950 € (0,00 %)     NYXOAH 1.368 € (-1,16 %)     ELIA GROUP 139.800 € (+1,60 %)     TESSENDERLO 20.900 € (+1,95 %)     KBC 122.650 € (+0,25 %)     BPOST 1.560 € (-0,64 %)     ORANGE BELGIUM 21.800 € (+0,46 %)     ECONOCOM GROUP 1.465 € (0,00 %)     COLRUYT 38.120 € (+0,47 %)     ONTEX GROUP 2.265 € (+2,49 %)     CFE 11.500 € (+0,44 %)     IBA 16.680 € (-0,36 %)     VIOHALCO 17.680 € (+2,67 %)     TEXAF 40.400 € (-2,42 %)     SHURGARD 25.550 € (+1,39 %)     KBC ANCORA 87.100 € (-0,11 %)     UCB 243.300 € (-0,25 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     TINC 11.340 € (+1,80 %)     CIE BOIS SAUVAGE 310.000 € (+2,99 %)     SOLVAC NOM(RETAIL) 77.500 € (+3,33 %)     PROXIMUS 6.135 € (+1,24 %)     SOLVAY 26.140 € (+0,62 %)     ONWARD MEDICAL 2.475 € (-0,40 %)     AGFA-GEVAERT 0.400 € (+1,39 %)     GBL 77.850 € (+0,84 %)     ACKERMANS V.HAAREN 269.800 € (+0,45 %)     JENSEN-GROUP 85.800 € (+1,90 %)     SIPEF 93.900 € (+1,62 %)     VAN DE VELDE 30.100 € (+1,69 %)     HOME INVEST BE. 19.860 € (+2,06 %)     CENERGY 21.560 € (+1,41 %)     AGEAS 72.050 € (+1,77 %)     BELYSSE GROUP 0.510 € (+6,25 %)     TUBIZE-FIN 210.000 € (+0,48 %)     BREDERODE 103.000 € (0,00 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     VASTNED 29.400 € (+0,34 %)     ARGENX SE 758.400 € (-0,24 %)     RECTICEL 12.120 € (+0,83 %)     AEDIFICA 70.400 € (+0,72 %)     ASCENCIO 51.600 € (+0,19 %)     CAMPINE 207.000 € (+0,49 %)     AZELIS GROUP 10.480 € (-0,29 %)     GIMV 44.850 € (+0,67 %)     D'IETEREN GROUP 176.000 € (+2,09 %)     BARCO 8.000 € (+2,63 %)     DECEUNINCK 2.190 € (+0,69 %)     RETAIL ESTATES 68.500 € (+1,33 %)     EVS 27.000 € (+0,37 %)     SYENSQO 69.700 € (+0,58 %)     UMICORE 20.280 € (+1,60 %)     CARE PROPERTY INV. 12.680 € (+0,32 %)  
   SAFRAN 327.300 € (+1,36 %)     BNP PARIBAS ACT.A 106.780 € (+1,54 %)     PLANISWARE 20.050 € (+0,25 %)     PROSUS 37.110 € (-3,60 %)     CRCAM MORBIHAN CCI 110.000 € (-0,09 %)     ENGIE 27.560 € (+1,96 %)     SOCIETE GENERALE 78.060 € (+1,11 %)     ALFEN 13.550 € (-1,38 %)     BE SEMICONDUCTOR 248.100 € (+3,59 %)     TIKEHAU CAPITAL 17.300 € (-0,35 %)     ARTMARKET COM 2.600 € (+11,11 %)     PERNOD RICARD 63.140 € (+0,86 %)     EXOSENS 61.950 € (+2,57 %)     EUROPLASMA 0.001 € (-16,67 %)     SCHNEIDER ELECTRIC 269.000 € (+0,07 %)     ABIONYX PHARMA 1.920 € (+3,00 %)     AIR LIQUIDE 176.740 € (+0,12 %)     STELLANTIS NV 5.092 € (+0,20 %)     STMICROELECTRONICS 58.270 € (+1,78 %)     GRAINES VOLTZ 18.000 € (-0,83 %)     ASM INTERNATIONAL 895.400 € (-0,80 %)     GROUPE OKWIND 0.215 € (-10,42 %)     CROSSJECT 1.544 € (-2,03 %)     MICHELIN 35.010 € (-0,14 %)     ACCOR 46.290 € (-0,15 %)     ASML HOLDING 1 589.600 € (-0,24 %)     WOLTERS KLUWER 59.980 € (-0,03 %)     CARREFOUR 16.650 € (+0,63 %)     TOTALENERGIES 74.290 € (+2,03 %)     ING GROEP N.V. 29.215 € (+0,53 %)     ELIS 25.400 € (+0,79 %)     CVC CAPITAL 14.300 € (-0,83 %)     ADYEN 820.900 € (+0,04 %)     AKZO NOBEL 58.140 € (+1,71 %)     LVMH 474.000 € (-0,95 %)     AIRBUS 208.300 € (+7,04 %)     HERMES INTL 1 679.500 € (-0,09 %)     REXEL 38.210 € (+0,26 %)     LARGO 1.520 € (+4,11 %)     UNILEVER 54.090 € (+1,22 %)     KERING 250.750 € (-0,08 %)     CHRISTIAN DIOR 440.000 € (0,00 %)     RELX 28.880 € (-0,07 %)     RAPID NUTRITION 4.070 € (+13,69 %)     ABIVAX 115.400 € (-1,79 %)     BUREAU VERITAS 27.220 € (+0,59 %)     JCDECAUX 22.140 € (+1,28 %)     L'OREAL 380.650 € (+0,50 %)     FUGRO 9.785 € (+1,19 %)     TELEPERFORMANCE 54.260 € (+1,76 %)     QUADIENT 12.880 € (+0,94 %)     AEGON 8.074 € (+0,67 %)     GTT 192.000 € (+1,27 %)     VALEO 13.310 € (+2,11 %)     AMUNDI 87.900 € (-1,18 %)     DASSAULT SYSTEMES 17.760 € (-0,89 %)     FRANCAISE ENERGIE 27.150 € (-6,38 %)     MAGNUM 15.884 € (+0,43 %)     WORLDLINE 10.050 € (-1,08 %)     ARVERNE GROUP 8.960 € (-0,44 %)  
News Réglementées
22/07/2026 09:00

Original-Research: MHP Hotel AG (von NuWays AG): BUY

Original-Research: MHP Hotel AG - from NuWays AG

22.07.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to MHP Hotel AG

Company Name:MHP Hotel AG
ISIN:DE000A3E5C24
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 3.7
Target price on sight of:12 months
Last rating change:
Analyst:Philipp Sennewald

MHP Hotel AG: Record Q2 revenue as hotel platform scales

Yesterday, MHP released Q2 '26 hotel performance figures, posting the highest quarterly revenue in the company's history. In detail:

Q2 hotel sales increased 26% yoy to € 56.8m (eNuW: € 57.8m), driven by the continuous expansion of the portfolio, most notably the first full quarterly consolidation of the Hyatt Regency Vienna and the ongoing Conrad Hamburg ramp-up. Moreover, demand in the premium and luxury segment remains strong. Important to mention in this context: In FY25, middle-east customer accounted for only 2.5% of Logis sales, explaining the limited effect on MHP operations.

Growth was broad-based across segments: Logis sales rose 22% to € 42.9m while F&B sales again grew disproportionately at +41% yoy to € 12.5m, following +36% in Q1. The continued outperformance of the gastronomy and conference business confirms the structural build-out of revenue sources beyond the room business, a strength that plays well into the equity story given its brand-building character and reduced dependency on room rates.

KPI picture: Volume ahead, rates slightly softer. Occupancy came in at 79% (eNuW: 78.7%), or a strong 82% adjusted for the Conrad Hamburg ramp-up (+2pp yoy), underpinning the intact volume demand across the portfolio. Rates on the other hand fell short of our expectations as ADR declined to € 229 or € 225 adj. (eNuW: € 237; Q2'25: € 238) and RevPar to € 180 (€ 184 adj; eNuW: € 186). The deviation is largely explained by two temporary effects: (1) the Conrad ramp-up during the seasonally weak start of the year in the Hamburg market and (2) a demand dip in April amid the geopolitical tensions in the Middle East.

Important to mention in this context: In FY25, middle-east customers accounted for only 2.5% of Logis sales, explaining the limited effect on MHP operations. Management also confirmed that April marked the trough of the FY26 demand development, with occupancy picking up clearly towards the end of Q2. That said, the Q2 rate development shows that the indirect sentiment effects were temporarily more visible than the limited direct exposure would suggest, which we regard as fully digestible given the swift occupancy recovery.

FY26 guidance confirmed. Management reiterated its outlook of c. € 225m sales (eNuW: € 227m) and > € 10m group EBITDA (eNuW: € 10.2m), driven by the first full-year contribution of the Conrad and the integration of the Hyatt Regency Vienna. Mind you, Q3 and Q4 are seasonally the strongest quarters, making the implied H2 top-line performance of € 127m or +28.2% yoy look achievable.

Overall, the release confirms the growth trajectory of the platform while the temporary rate softness does not alter the underlying investment case of a scaling, asset-light premium operator with strong cash conversion and a committed pipeline (Sheraton Vienna 2027, AC Stuttgart 2028, MOOONS Frankfurt 2029, AC Düsseldorf 2029).

Reiterate BUY with an unchanged PT of € 3.70 based on DCF.
 

You can download the research here: mhp-hotel-ag-2026-07-22-previewreview-en-a3f0f
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2369646  22.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière